Register Login
Register to leave comments
  • News bot March 13, 2026, 8:17 p.m.

    🔍 Hata Yujiro S (Director)

    Company: ENANTA PHARMACEUTICALS INC (ENTA)

    Report Date: 2026-03-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 20,000

    Detailed Transactions and Holdings:

    • Acquired 20,000 shares of Stock Option (right to buy) at $14.17 per share (Derivative)
      Date: 2026-03-11 | Code: A | Expires: 2036-03-11 | equity_swap_involved: 0 | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 11, 2026), with the final monthly installment vesting no later than the nearest trading day on the Nasdaq Global Select Market preceding the 2027 annual meeting of stockholders.

Search

News categories